CN Patent

CN106317114B — 一种磷酸特地唑胺的制备方法

Assigned to Nanjing Yoko Biological Pharmaceutical Group Co Ltd · Expires 2018-11-20 · 7y expired

What this patent protects

本发明公开了一种磷酸特地唑胺的制备方法,具体包括:以N‑[3‑氟‑4‑[6‑(2‑甲基‑2H‑四唑‑5‑基)‑3‑吡啶基]苯基]氨基甲酸苄酯为起始原料,在R 1 ‑O‑M、1,3‑二甲基‑3,4,5,6‑四氢‑2‑嘧啶酮存在下,与R‑缩水甘油丁酸酯反应,再用POCl 3 磷酸酯化得到磷酸特地唑胺粗品,用碱溶液调pH值为7~9将其转换为盐,再用盐酸调pH值至1~2得到精制品磷酸特地唑胺。本发明具有反应条件温和,成本较低,操作简便,副反应较少,收率高,反应重现性好,经济环保且适于工业化生产的优点。

USPTO Abstract

本发明公开了一种磷酸特地唑胺的制备方法,具体包括:以N‑[3‑氟‑4‑[6‑(2‑甲基‑2H‑四唑‑5‑基)‑3‑吡啶基]苯基]氨基甲酸苄酯为起始原料,在R 1 ‑O‑M、1,3‑二甲基‑3,4,5,6‑四氢‑2‑嘧啶酮存在下,与R‑缩水甘油丁酸酯反应,再用POCl 3 磷酸酯化得到磷酸特地唑胺粗品,用碱溶液调pH值为7~9将其转换为盐,再用盐酸调pH值至1~2得到精制品磷酸特地唑胺。本发明具有反应条件温和,成本较低,操作简便,副反应较少,收率高,反应重现性好,经济环保且适于工业化生产的优点。

Drugs covered by this patent

Patent Metadata

Patent number
CN106317114B
Jurisdiction
CN
Classification
Expires
2018-11-20
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Yoko Biological Pharmaceutical Group Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.